Amarex logo

The 505(b)(2) Drug Development Pathway: When and How to Take Advantage of a Unique American Regulatory Pathway

The 505(b)(2) regulation offers a less expensive and faster new drug development pathway that may be particularly attractive to a manufacturer with experience in developing generic products.

Contact Us

Book a meeting or send us a message to talk to one of our experts.